Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 11-12, 2005, Pages 1139-1146

  Nardone, G ^a   Rocco, A ^a   Staibano, S ^a   Mezza, E ^a   Autiero, G ^a   Compare, D ^a   De Rosa, G ^a   Budillon, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; POPULATION RESEARCH; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEROLOGY; STOMACH MUCOSA;

ADULT; AGED; CHRONIC DISEASE; DYSPEPSIA; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 28844451148     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02734.x     Document Type: Article

References (40)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504.
2. American Cancer Society. Estimated New Cancer Cases and Deaths by Sex for all Sites, United States, 2000 (table). Available at: http://www.cancer.org/ statistics/cff2000/data/newCaseSex.html, 2000. (Last accessed 3 May 2002).
3. Cheli R, Giacosa A, Pirasso A. Chronic gastritis: a dynamic process toward cancer. In: Ming, SC, ed. Precursor of Gastric Cancer. New York, USA: Praeger Scientific, 1984; 117-29.
4. Borchard F. Precancerous conditions and lesions of stomach. In: Rugge, M, Arslan-Pagnini, C, Di Mario, F, eds. Carcinoma gastrico e lesioni pricancepose deuo stomaco. Milan, Italy: Edizioni Uniscopi, 1986; 175-210.
5. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol 1984; 104: 131-6.
6. Sipponen P. Gastric cancer - a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol 1994; 29 (Suppl. 201): 24-7.
7. El-Zimaity HM, Graham DY, Al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996; 27: 35-41.
8. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-59.
9. Genta RM. Gastric atrophy and atrophic gastritis - nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998; 12: 17-23.
10. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The Updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
11. Zaitoun AM, Al Mardini H, Record CO. Quantitative assessment of gastric atrophy using the syntactic structure analysis. J Clin Pathol 1998; 51: 895-900.
12. Ruiz B, Garay J, Correa P, et al. Morphometric evaluation of gastric antral atrophy: improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001; 96: 3281-7.
13. Staibano S, Rocco A, Mezza E, et al. Diagnosis of chronic atrophic gastritis by morphometric image analysis. A new method to overcome the confounding effect of the inflammatory infiltrate. J Pathol 2002; 198: 47-54.
14. Dinis-Ribeiro M, Yamaki G, Miki K, et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004; 11: 141-7.
15. Bodger K, Wyatt JI, Heatley R. Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy. Helicobacter 2001; 6: 216-24.
16. Di Mario F, Moussa AM, Caruana P, et al. 'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection. Scand J Gastroenterol 2003; 38: 1223-7.
17. Hartleb M, Wandzel P, Waluga M, et al Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies. Acta Gastroenterol Belg 2004; 67: 320-6.
18. Pasechnikov VD, Chukov SZ, Kotelevets SM, et al. Possibility of non-invasive diagnosis of gastric mucosal precancerous changes. World J Gastroenterol 2004; 10: 3146-50.
19. Urita Y, Hike K, Torii N, et al. Serum pepsinogens as predictor of the topography of intestinal metaplasia in patients with atrophic gastritis. Dig Dis Sci 2004; 49: 795-801.
20. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15: 885-91.
21. McColl KE, el-Omar EM, Gillen D. Alterations in gastric physiology in Helicobacter pylori infection: causes of different diseases or all epiphenomena? Ital J Gastroenterol Hepatol 1997; 29: 459-64.
22. Broutet N, Plebani M, Sakarovitch C, et al. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88: 1239-47.
23. Inoue M, Kobayashi S, Matsuura A, et al. Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidemiol Biomarkers Prev 1998; 7: 261-3.
24. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol 2003; 15: 877-9.
25. Ricci C, Vakil N, Rugge M, et al. Serological markers for gastric atrophy in asymptomatic patients infected with Helicobacter pylori. Am J Gastroenterol 2004; 99: 1910-5.
26. Ley C, Mohar A, Guarner J, et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 2001; 10: 107-12.
27. Zweig MH, Campbell G. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77.
28. Altman DG. Diagnostic tests. In: Altman, DG, Machin, D, Trevor, NB, Gardner, MJ, eds. Statistics with Confidences, 2nd edn. London: BMJ Books, 2000; 105-19.
29. Dursun M, Yilmaz S, Yukselen B, et al. Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia. Hepatogastroenterology 2004; 51: 1732-5.
30. Shiotani A, Iishi H, Uedo N, et al. Histologic and serum risk markers for non-cardia early gastric cancer. Int J Cancer 2005; 115: 463-9.
31. Bodger K, Wyatt JI, Heatley RV. Serologic screening before endoscopy: the value of Helicobacter pylori serology, serum recognition of the CagA and VacA proteins, and serum pepsinogen I. Scand J Gastroenterol 1999; 34: 856-63.
32. Fukuda Y, Isomoto H, Ohnita K, et al. Impact of CagA status on serum gastrin and pepsinogen I and II concentrations in Japanese children with Helicobacter pylori infection. J Int Med Res 2003; 31: 247-52.
33. Locke CR III, Talley NJ, Nelson DK, et al. Helicobacter pylori and dyspepsia: a population based study of the organism and host. Am J Gastroenterol 2000; 95: 1906-13.
34. Navaglia F, Basso D, Piva MG, et al. Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology. Am J Gastroenterol 1998; 93: 227-30.
35. Nobuta A, Asaka M, Sugiyama T, et al. Helicobacter pylori infection in two areas in Japan with different risks for gastric cancer. Aliment Pharmacol Ther 2004; 20: 1-6.
36. Oksanen A, Sipponen P, Karttunen R, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000; 46: 460-3.
37. Parente F, Imbesi V, Maconi G, et al. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients. Am J Gastroenterol 1998; 93: 1073-9.
38. Sande N, Nikulin M, Nilsson I, et al. Increased risk of developing atrophic gastritis in patients infected with CagA+ Helicobacter pylori. Scand J Gastroenterol 2001; 36: 928-33.
39. Karnes WE Jr, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167-74.
40. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-43.